| abstract |
The present invention relates to compositions, formulations, methods and systems for the treatment of topical fat accumulation and fat related conditions, skin diseases and muscle diseases. The method comprises administering a composition comprising one or more compounds that reduce the desensitization of beta adrenergic receptors, such as glucocorticosteroids and / or one or more long acting beta-2 adrenergic receptor agonists such as formoterol. The compositions to be administered include sustained release preparations comprising one or more long acting beta-2 adrenergic receptor agonists, one or more compounds that reduce desensitization of the beta adrenergic receptor, or both in the form of sustained crystalline particulates. |